Literature DB >> 19756256

Nonlinear Random Effects Mixture Models: Maximum Likelihood Estimation via the EM Algorithm.

Xiaoning Wang1, Alan Schumitzky, David Z D'Argenio.   

Abstract

Nonlinear random effects models with finite mixture structures are used to identify polymorphism in pharmacokinetic/pharmacodynamic phenotypes. An EM algorithm for maximum likelihood estimation approach is developed and uses sampling-based methods to implement the expectation step, that results in an analytically tractable maximization step. A benefit of the approach is that no model linearization is performed and the estimation precision can be arbitrarily controlled by the sampling process. A detailed simulation study illustrates the feasibility of the estimation approach and evaluates its performance. Applications of the proposed nonlinear random effects mixture model approach to other population pharmacokinetic/pharmacodynamic problems will be of interest for future investigation.

Year:  2007        PMID: 19756256      PMCID: PMC2743159          DOI: 10.1016/j.csda.2007.03.008

Source DB:  PubMed          Journal:  Comput Stat Data Anal        ISSN: 0167-9473            Impact factor:   1.681


  5 in total

Review 1.  Pharmacogenomics: translating functional genomics into rational therapeutics.

Authors:  W E Evans; M V Relling
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

2.  Bayesian nonparametric population models: formulation and comparison with likelihood approaches.

Authors:  J Wakefield; S Walker
Journal:  J Pharmacokinet Biopharm       Date:  1997-04

3.  Modelling of individual pharmacokinetics for computer-aided drug dosage.

Authors:  L B Sheiner; B Rosenberg; K L Melmon
Journal:  Comput Biomed Res       Date:  1972-10

4.  Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models.

Authors:  G L Rosner; P Müller
Journal:  J Pharmacokinet Biopharm       Date:  1997-04

5.  Pharmacokinetic-pharmacodynamic-efficacy analysis of efalizumab in patients with moderate to severe psoriasis.

Authors:  Chee M Ng; Amita Joshi; Russell L Dedrick; Marvin R Garovoy; Robert J Bauer
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

  5 in total
  6 in total

1.  Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models.

Authors:  Jurgen B Bulitta; Cornelia B Landersdorfer
Journal:  AAPS J       Date:  2011-03-04       Impact factor: 4.009

2.  An Algorithm and R Program for Fitting and Simulation of Pharmacokinetic and Pharmacodynamic Data.

Authors:  Jijie Li; Kewei Yan; Lisha Hou; Xudong Du; Ping Zhu; Li Zheng; Cairong Zhu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

3.  Joint model-based clustering of nonlinear longitudinal trajectories and associated time-to-event data analysis, linked by latent class membership: with application to AIDS clinical studies.

Authors:  Yangxin Huang; Xiaosun Lu; Jiaqing Chen; Juan Liang; Miriam Zangmeister
Journal:  Lifetime Data Anal       Date:  2017-10-27       Impact factor: 1.588

4.  Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian.

Authors:  Tatiana Tatarinova; Michael Neely; Jay Bartroff; Michael van Guilder; Walter Yamada; David Bayard; Roger Jelliffe; Robert Leary; Alyona Chubatiuk; Alan Schumitzky
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-02-13       Impact factor: 2.745

5.  Population Pharmacokinetic/Pharmacodyanamic Mixture Models via Maximum a Posteriori Estimation.

Authors:  Xiaoning Wang; Alan Schumitzky; David Z D'Argenio
Journal:  Comput Stat Data Anal       Date:  2009-10-01       Impact factor: 1.681

6.  Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice.

Authors:  Xi-Ling Jiang; Hong-Wu Shen; Donald E Mager; Stephan Schmidt; Ai-Ming Yu
Journal:  Acta Pharm Sin B       Date:  2016-08-06       Impact factor: 11.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.